Summary. The effects of insulin on renal haemodynamics and renal sodium handling were studied in 10 healthy males. Using the euglycaemic insutin clamp technique, insulin was infused on separate days resulting in two levels of hyperinsulinaemia (41 + 3 and 90 +_ 7 mU/1,respectively). Renalhaemodynamics and the proximal and distal tubular sodium handlingwere studied using inulin, para-amino-hippuric acid, sodium and lithium clearances. Low-and high-dose insulin infusions were followed by a fall in sodium clearance from 1.6 + 0.1 ml/min to t.2 +_0.1 and 1.0+0.1 ml/min, respectively. Both levels of hyperinsulinaemia resulted in increased distal tubular sodium reabsorption. The distal antinatriuretic effect of insulin was associated with dose-and time -dependent decline in proximal tubular sodium reabsorption. The changes in proximal tubular sodium handling occurred without any significant changes in natriuretic factors, such as renal dopamine and plasma atrial natriuretic peptide levels. However, hyperinsulinaemia resulted in time-and dose-dependent increases in renal plasma flow, and renal vasodilatation could, possibly via changes in renal interstitial pressure, have contributed to the fall in the proximal tubular sodium reabsorption. The results also suggest that decreased proximal sodium reabsorption may be a compensatory mechanism counteracting the insulin-induced sodium retention.
The antinatriuretic effect of insulin is well documented, and most studies indicate that acutely-induced hyperinsulinaemia produces its antinatriuretic effect by stimulating sodium reabsorption in the distal tubule [1] [2] [3] [4] . However, conditions characterized by hyperinsulinaemia, such as essential hypertension and obesity are not characterized by increased total body exchangeable sodium, which suggests that the antinatriuretic effect of insufin is transient. It therefore seems likely that compensatory mechanism(s), counteracting the acute stimulatol~ effects of insulin on distal tubular sodium reabsorption become operative. In a micropuncture study in dogs, using high physiological to supraphysiological insulin levels, DeFronzo et al. [1] observed that insulin-stimulated distal sodium reabsorption was associated with a decreased sodium reabsorptionin the proximal tubule. One can speculate that decreased proximal sodium reabsorption may be a compensatory mechanism counteracting the insulin-induced sodium retention. We therefore wished to determine whether sodium retention induced by physiological hypminsulinaemia in man is accompanied by changes in proximal sodium handling. Using the euglycaemic hyperinsulinaemic clamp technique and lithium clearance, we investigated the effects of two levels of hyperinsulinaemia on renal tubutar sodium handling. The effects of hyperinsulinaemia on factors which may mediate proximal tubular natriuresis, such as changes in renal haemodynamics and natriuretic factors, including renal dopamine and plasma atrial natriuretic peptide levels, were also investigated.
Subjects and methods

Subjects
Ten healthy males aged 27-36 years (mean age 32.8 +_ 0.9 years) were studied. All were normotensive and none was on medication. The subjects were advised to continue their usual diets and were maintained on an ad libitum sodium and protein diet prior to the studies. Their mean body mass index was 23.5 _+ 0.5 kg/m z (range 21.8-26.2 kg/m2). All subjects gave their informed consent and approval was obtained from the local ethics committee.
Methods
The subjects received 16.2 mmol of lithium orally, as lithium carbonate, the evening before the clearance study, and then fasted overnight. On the morning of the investigation they drank 500 ml of tap water. At 08.00 hours infusions of 20 % para-amino-hippuric acid (PAH; Merck Sharp and Dohme, West Point, PA., USA; 0.2 ml/kg body weight, rate -0.5 ml/min) and 25 % inulin (Inutest; Kemiflor, Stockholm, Sweden; 0.2 ml/kg body weight, rate -0.5 ml/min) were started through an indwelling cannuta in a lower arm vein to estimate renal plasma flow (RPF) and glomerular filtration rate (GFR), respectively. After a 2-h equilibration period timed urine collections were started. To ensure adequate diuresis, 300 ml of tap water was given orally each hour. During the study period the subjects were in the supine position, except when voiding urine. Systolic blood pressure, diastolic blood pressure and heart rate were measured every 45 min by standard methods. During the investigation, each subject kept one hand in a heated (64 °C) plexiglass box to permit sampling of arterialized venous blood [5] . The subjects voided urine every 45 rain and urine samples were analysed for inulin, PAH, lithium, dopamine and sodium. Blood samples for inulin, PAH, lithium, insulin, C-peptide, atrial natriuretic pepfide (ANP), plasma renin activity, adrenaline, noradrenaline, blood glucose, haematocrit and sodium were taken after each clearance period. After two basal 45-min clearance periods, insulin was infused (400 mU. m 2 as a bolus, followed by 20 mU. m-~. min-~) for three 45-min clearance periods. Insulin (Insulin Actrapid 100 U/I; Novo, Bagsva~rd, Denmark) was dissolved in 48 ml NaC1 (154 mmol/1) and 2 ml of the patient's blood and was infused through an antecubital vein. Arterialized blood samples were drawn fl'om a plastic catheter placed in a forearm vein in the same arm. The fasting blood glucose level was maintained by adjustment of the infusion rate of a 20 % glucose solution. Blood glucose was measured every 5 rain with an automated glucose oxidase method (Glucose analyzer II; Beckman Instruments AB, Fullerton, Calif., USA). On a second study day, after ar~ inter#al of at least 2 weeks the protocol was repeated in the same ten Subjects with the exception that insulin was given in a higher dose (800 mU -m 2 as a bolus, followed by 40 mU-m-Z, min-1).
Calculations
Mean arterial pressure was calculated as the diastolic blood pressure plus one third of the pulse pressure. Sodium, inulin, PAH and lithium clearances were calculated employing the usual formulas. The means of the inulin, PAH, lithium and sodium values at the beginning and end of each clearance period were used for the clearance calculations. The filtration fraction was determined by GFR/RPF as estimated by the inulin and PAH clearances, respectively. The method of lithium clearance described by Thomsen [6] is based on two assumptions: (1) lithium is reabsorbed in the proximal tubule in parallel with sodium and water, and (2) lithium is neither secreted nor reabsorbed beyond the proximal tubules. Hence, the fractional proximal tubular reabsorption of sodium was calculated as 1-(CLI/C~) x 100% and the fractional distal tubular sodium reabsorptions as 1-(CNjCL~)x t00%. The absolute proximal tubular reabsorption of sodium was calculated as P-Na. (Ct,-CLi)mmol/min and the absolute distal reabsorption of sodium was calculated as P-Na • (CLr-CN,) mmol/min.
Analyses
Urinary dopamine and serum levels of noradrenaline and adrenaline were analysed as previously described [7] . Specific radioimmunoassays were used to analyse ANP [8] , C-peptide [9] and plasma insufin [10] . Plasma renin activity was analysed with a commercial kit (Phadebas ANG-I test; OY Medix, Helsinki, Finland). The detection limit of the plasma renin activity assay was 0.3 gg-1 -i. h-~ 1 Values less than 0.3 gg. 1-i h-1 were treated as equal to 0.3 gg-1-1 h-1. Serum and urinary concentrations of lithium were measured by atomic absorption (Modell IL 751 AA Spectrophotometer; Instrumental Laboratory Inc., Wilmington, Del., USA) using the method previously described by Amdisen [11] with the exception that protein was precipitated with HNO3. To correct for the precipitation of protein, serum lithium concentrations were multiplied by a factor of 0.%5. Determinations of blood glucose, haematocrit and sodium were made in the Department of Clinical Chemistry, Huddinge Hospital, employing routine methods.
Statistical analysis'
Reported data represent the means of repeated measurements during basal conditions and during hyperinsulinaemia, respectively, as described above. There was no statistically significant difference between data obtained during basal conditions prior to the low-and high-dose insulin infusions (p > 0.73 for all parameters), and the means of data from the two study periods were therefore used for the analyses. All data are given as means + SEM. Non-parametric statis- 
Results
All results are shown in Tables 1-4 . Following insulin infusions at a rate of 20 mU-m -z. min-1 (low-dose insulin) and 40 mU.m-2-min '1 (high-dose insulin), the mean plasma insulin concentrations rose to 41 + 3 mUff and 90 + 7 mU/1, respectively. The mean plasma insulin levels in each insulin clamp period are shown in Figure 1 . The coefficient of variation for plasma insulin levels was 15 % following the low-dose insulin infusion and 22 % following the high-dose insulin infusion. There was a similar and significant (p <0.01) fall in C-peptide levels from 0.50 + 0.04 to 0.34 + 0.04 nmol/1 in response to both the low-dose and the high-dose insulin infusions. Euglycaemia (4.5 + 0.1 mmol/1) was maintained and the coefficient of variation for the plasma glucose concentrations was 6.2% following the low-dose insulin infusion and 5.5 % following high-dose insulin infusion. There was a rise in heart rate from 54 _+ 2 beats per min in the basal state to 58 + 2 beats per rain (NS) following the low-dose insulin infusion, and to 59 + 4 beats per rain (p < 0.05) following the high-dose insulin infusion. There were no significant changes in systolic or diastolic or mean arterial blood pressures in response to either of the insulin infusions (Table 1) . A significant (p < 0.05) 80 % rise in plasma renin activity was observed following the high-dose insulin infusion. Significant increases (p <0.01) (15% and 38%, respectively) in noradrenaline levels were seen in response to both the low-dose and the high-dose insulin infusions (Table 2 ) but serum adrenaline levels were not affected. Renal dopamine mobilisation, as estimated from the urinary excretion of dopamine, and plasma levels of ANP did not change from the basal level following either the lowor the high-dose insulin infusion (Table 2 ). Data on renal haemodynamic parameters during basal conditions and following insulin infusions are presented in Table 3 . A significant (p < 0.05) 10 % rise in renal plasma flow was seen following the high-dose insulin infusion whereas GFR was unchanged. The time-and dose-dependent changes in renal plasma flow following low and high-dose insulin infusions are shown in Figure 2 . Significant decreases in filtration fraction were seen following both insulin infusions. There was a small non-significant rise in the urine flow rate following the high-dose insulin infusion.
The change in the renal clearance of sodium is presented in Table 4 and the time-and dose-dependent falls in sodium clearance are shown in Figure 3 . Following the high-dose insulin infusion there was a significant rise (p <0.01) in lithium clearance from 30.0+1.1 to Figure 4 . The fractional proximal sodium reabsorption declined 1045 (p < 0.05) in response to high-dose insulin infusion from 73.7 + 1.1 to 68.2 + 1.5 %. The decrease in the absolute proximal tubular sodium reabsorption that was seen following high-dose insulin infusion did not reach statistical significance (p = 0.06). However, a gradual decrease over time in the absolute proximal tubular sodium reabsorption was observed in response to the high level of insulin infusion, as shown in Figure 5 .
Discussion
The present results confirm previous observations of a reduced sodium excretion following an acute increase in plasma insulin levels [1-4, 12, 13] . The plasma insulin levels recorded during the low-dose insulin infusion (41 + 3 mU,q) correspond to those observed postprandially in normal man and caused a 25 % reduction in sodium clearance. When the plasma insulin levels were raised to a submaximal physiological level (90 _+ 7 mUff), a 40 % reduction in sodium clearance was noted, suggesting that insulin causes an acute dose-dependent reduction in sodium excretion. The enhanced reabsorption of sodium following the insulin infusion in the present study was seen in conjunction with an unaffected GFR indicating, in agreement with previous observations, that the hormone directly stimulates sodium uptake at a tubular site [2, 3] . However, the tubular site of the antinatriuretic effect of insulin has been the subject of controversy. In dogs studied by the recollection micropuncture technique, insulin infusions leading to high physiological or supraphysiological plasma insulin levels reduced the urinary sodium excretion by 35-50 % by stimulating the distal tubular reabsorption. This occurred concomitantly with a significant decline in proximal tubular sodium reabsorption [1] . In contrast to this finding, insulin was observed to stimulate sodium reabsorption in rabbit proximal tubules studied by in vitro microperfusion [14] . Conflicting results have also been reported in human studies using lithium clearance to localize the insulin effect. Observations by SkCtt et al. [2] , Friedberg et al. [3] and NCrgaard et al. [4] indicate that physiological insulin levels stimulate sodium reabsorption at a distal tubular site, whereas the results of Trevisan et al. [15] suggest that insulin produces its antinatriuretic effect in the proximal tubule.
In the present study, we used the renal lithium clearance technique to measure the output of sodium from the proximal tubules. The limitations of the lithium clearance technique have been discussed by others [16, 17] . Since blood glucose was kept constant and normal during the insutin infusion and the subjects were adequately hydrated and sodium-repleted during the experiments, glucosuria, dehydration and sodium depletion can be excluded as potential confounding factors. The increase in lithimn clearance during insulin infusion, as shown in the present study, was therefore most probably due to a direct or indirect effect of insulin on the proximal tubule, although it cannot be excluded that a part of the increase in lithium excretion seen following the insulin infusion was due to inhibition of lithium reabsorption in Henle's loop. However, since Kirchner et aI. [18] found that the insulin infusion it is believed that sodium and lithium are transported in the same direction in those segments where both are handled, the latter possibility seems unlikely. Our results indicate that insulin causes sodium retention by a dose-dependent stimulatory effect on sodium reabsorption in the distal tubule, as evaluated by both an increase in the absolute (mmol/min) and fractional (%) distal sodium reabsorption, using the lithium clearance technique. A distal tubular effect of insulin accords with the observation that this part of the nephron exhibits the highest density of insulin receptors [19] . Moreover, insulin stimulates Na+K+ATPase [20] , a cation transport system which is abundant in the distal tubules [21] . The receptors are located at the basolateral aspect of the tubules accessible from the blood stream and there is an excellent correlation between Na+K+ATPase-activity and the reabsorptive capacity in the distal tubules [22] . The present study indicates that physiological hyperinsulinaemia causes a gradual decline in the proximal tubular sodium reabsorption in conjunction with a stimulated distal tubular sodium reabsorption. This is in accordance with the micropuncture findings in dogs by DeFronzo et al. [1] and the increase in lithium clearance found by Friedberg et al. [3] but in contrast to the unchanged lithium clearance seen in the study by SkCtt et al. [2] . The discrepancy between our results and those of Skctt et al. may depend on differences in the experimental protocols and in the dose of insulin given. In the present study the effects of low-and high-dose insulin infusions were determined during three consecutive clearance periods of 45 min each, and we observed a dose-and time-dependent effect of insulin on both the distal and proximal sodium handling, although in opposite directions. Significant increases in distal sodium reabsorption were observed during the first 45-rain clearance period after induction of both levels of hyperinsulinaemia. However, it should be noted that whereas the higher plasma insulin level resulted in a prompt decrease in the fractional proximal tubular sodium reabsorption, there was a delayed attenuation of the fractional proximal sodium reabsorption in response to the lower insulin dose and a statistically significant change from basal values was not observed until the second 45-min clearance period after induction of hyperinsulinaemia. This suggests that there was a time-lag between the increase in distal sodium reabsorption and the attenuation of proximal sodium reabsorption, the delay being more pronounced at the lower level of hyperinsulinaemia. It is therefore tempting to speculate that insulin-stimulated distal sodium reabsorption resulting in sodium retention and expansion of the extraceltular fluid volume led to inhibition of proximal sodium reabsorption. While insulin has been shown to increase the proximal sodium reabsorption in studies performed in vitro [14, 23, 24] , studies performed in vivo have failed to demonstrate increased proximal tubular sodium reabsorption in response to insulin in humans [2] [3] [4] , dogs [1] or rats [18] . The reason for the discrepancy between the in vitro and in vivo effects of insulin on proximal sodium reabsorption remains unclear. If the antinatriuretic action of insulin were to be sustained, expansion of the extracellular volume would ensue, and inhibition of the proximal tubular sodium reabsorption might be a mechanism present only in the intact animal which protects it from the soditun-retaining effects of insulin. Indeed, neither essential hypertension nor obesity are characterized by increased total body exchangeable sodium [25, 26] while increased total exchangeable sodium is a typical finding in diabetes [27] . Moreover, studies in dogs have shown that chronic hyperinsulinaemia induced by insulin infusion for 7 days fails to cause hypertension and, following a decrease in sodium excretion during the first 2-3 days, natriuresis returns towards basal values by an "escape-mechanism" of unknown aetiology [28] .
Information is limited concerning the effects of acute insulin infusion on endogenous natriuretic factors, such as renal dopamine and ANR Renal dopamine stimulates sodium excretion by a rapid and reversible inhibition of Na ÷ K ÷ ATPase in the proximal tubule [29] . The renal mobilisation of dopamine, as reflected by urinary dopamine excretion, was not affected by hyperinsulinaemia in the present study, rendering a dopamine-mediated inhibition of proximal sodium reabsorption unlikely. In a previous study by Trevisan et al. [15] , insulin administration for 24 h raised ANP levels in non-diabetic subjects whereas in the present study plasma ANP levels were not affected by hyperinsulinaemia for 2 h and 15 min, thus suggesting that the ANP changes are secondary to plasma expansion and not to insulin itself. Our results suggest that ANP does not mediate the fall in proximal tubular sodium reabsorption following insulin infusion. In the present study hyperinsulinaemia within the moderately high to submaximal physiological range resulted in unchanged systemic blood pressure and GFR, significantly increased renal plasma flow and reduced the filtration fraction, indicating a direct vasodilatory effect of insulin similar to the vasodilatory effect of angiotensin-converting enzyme inhibition. Cohen et al. [30] have shown that insulin has a significant renal vasodilatory effect and that the vasoconstrictor response to angiotensin II can be attenuated by physiological hyperinsulinaemia in the isolated rat kidney. Direct vasodilatory properties of insulin have previously been demonstrated in vitro [31] and vasodilatation has also been observed in human skeletal muscle following hyperinsulinaemia [32] . One can speculate that the observed renal vasodilatation resulted in a fall in the proximal tubular sodium reabsorption, possibly mediated by changes in the renal interstitial pressure [33, 34] . The increases in serum levels of noradrenaline and heart rate observed in the present study agree with the findings by Rowe et al. [35] and may be a secondary reflex phenomenon to compensate for a fall in systemic vascular resistance.
In conclusion, the present study demonstrates that insulin produces an acute dose-dependent antinatriuretic effect by stimulating distal tubular sodium reabsorption. Under the present experimental conditions hyperinsulinaemia is also associated with decreased proximal sodium reabsorption. The mechanism(s) causing the fall in proximal tubular sodium reabsorption are not clear. The present data do not support the concept of a contributory role of ANP or of renal dopamine. However, in view of the observed increases in renal plasma flow, renal vasoditatation following the induction of hyperinsulinaemia could have contributed to this alteration. If the attenuation of the proximal sodium reabsorption is maintained during chronic hyperinsulinaemia, this could be a counter-regulatory mechanism balancing the antinatriuretic effect of insulin in the distal tubule and thus preventing expansion of the extracellular fluid volume.
